secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2023-09-07T23:59:59+00:00
Accession:  0001193125-23-230611
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aligos receives Nasdaq delisting notice for bid price below $1.00
-----------------------------------------------------------------

- Notice on Sep 5, 2023: stock failed to maintain $1.00 minimum bid for 30 consecutive business days through Sep 1.
- Company has 180 calendar days, until Mar 4, 2024, to regain compliance by closing at $1.00 for 10 consecutive days.
- If not cured, Aligos may be eligible for an additional 180-day period by transferring to Nasdaq Capital Market.
- Company intends to monitor bid price and consider options, but compliance is not assured.
- Potential delisting could occur if Staff determines cure is unlikely or other standards unmet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523230611/0001193125-23-230611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312523230611/d549184d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-230611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer